Medication-Assisted Treatment (MAT)

those that provide information about medication- assisted therapy for patients with unhealthy alcohol use or alcohol use disorder, including the use of medications approved by the Food and Drug Administration for the treatment of alcohol use

Integrating SUD and OB/GYN Care: Policy Challenges and Opportunities Final Report

This report aims to address the treatment opportunities for pregnant and postpartum (or parenting) women (PPW) with substance use disorder (SUD) by describing opportunities to integrate obstetricians and gynecologists (OB/GYN) and SUD care as well as barriers to integrated care delivery.

Medications for Alcohol Use FAQ

Alcohol is the third leading cause of preventable death in the United States, making it a key public health issue. This document is designed to provide information and answer common questions primary care clinicians may have about medications prescribed for the treatment of alcohol use disorder.

What Can Primary Care Services Do to Help First Nations People with Unhealthy Alcohol Use? A Systematic Review: Australia, New Zealand, USA and Canada

Reviews 28 studies about alcohol treatments delivered in primary care settings, finding that trials of naltrexone and disulfiram had positive results, but that more studies are needed to assess the effectiveness of the full scope of alcohol treatment

Trends in the Use of Naltrexone for Addiction Treatment Among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities

Study looking at the use of naltrexone for alcohol use disorder in substance use treatment facilities, showing that naltrexone is more commonly prescribed compared with acamprosate and disulfiram but that it remains underused

Treatment of Alcohol Use Disorder

Includes an infographic guide on the benefits of three medications for alcohol use disorder and provides a brief summary of treatment planning and medications approved by the Food and Drug Administration

Treatment Interventions to Maintain Abstinence from Alcohol in Primary Care: Systematic Review and Network Meta-analysis

Reviews 64 trials of alcohol use treatment in primary care, finding that acamprosate is the only intervention with moderate confidence associated with increased abstinence

The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review

Reviews the use of disulfiram, acamprosate, and naltrexone for alcohol use disorder (AUD) in primary care, and concludes that the knowledge and prescription of pharmacotherapy for AUD is insufficient

Tele-Treatment for Substance Use Disorders

This is a best practice guide about using telehealth for the treatment of substance use disorders, including information about screening, brief intervention, and referral to treatment.

Screening for and Managing At-Risk Drinking and Alcohol Use Disorder (AUD) During COVID-19

Supplements the CEP's AUD Tool by supporting primary care physicians in screening and managing AUD during the COVID-19 pandemic

Rates of Discontinuation and Non-Publication of Trials for the Pharmacologic Treatment of Alcohol Use Disorder

Identifies clinical trials on medication-assisted treatment for alcohol use disorder from ClinicalTrials.gov, finding that 12.6% involving pharmaceutical treatment were prematurely terminated and 39.1% had not published results

Subscribe to Medication-Assisted Treatment (MAT)